Skip to main content
. 2022 Jan 10;2022(1):CD002990. doi: 10.1002/14651858.CD002990.pub4

Walters 2013.

Study characteristics
Methods Design: CRT Follow‐up: 12 months Control group: usual care
Participants Recruitment: general practice
Assessed for eligibility: 1207
Randomly assigned: SM: 90; UC: 92
Completed: SM: 74; UC: 80
Mean age: SM: 68.2 (SD 7.9) years; UC: 67.3 (SD 7.6) years
Gender (% male): SM: 54; UC: 51
COPD diagnosis: postbronchodilator FEV1/FVC < 0.7, FEV1 30‐80%
Inclusion of participants in acute phase: not reported
Major inclusion criteria: smoking history > 10 pack‐years, postbronchodilator FEV1/FVC < 0.7, FEV1 30% to 80%; able to complete procedures and provide informed consent
Major exclusion criteria: unable to participate in self‐care activities due to mental or physical incapacity, end‐stage cancer, poor English language skills and nursing home resident
Interventions Mode: mentor telephone call sessions
Duration: 16 individual phone calls (30 min each)
Professional: community health nurses
Assignment of case managers: yes, accessible to participants during the complete follow‐up period
Self‐management components: smoking cessation (optional), self‐recognition of COPD exacerbations, use of a COPD exacerbation action plan, physical activity (optional), diet (optional), COPD medication intake (optional), alcohol (optional), psychosocial (optional)
Self‐management topics: not reported
Behavioural change techniques: 5 clusters: goals and planning, feedback and monitoring, social support, shaping knowledge, self‐belief
Outcomes 1. Quality of life (SF‐36 and SGRQ)
2. Patients' self‐management behaviour and knowledge (PIH scale)
3. Self‐efficacy (SEMCD)
4. Anxiety and depression (HADS, CES‐D and PCL‐C)
5. Well‐being (SWLS)
6. Hospital admissions
Notes Source of funding: this work was supported by the National Health and Medical Research Council (NHMRC) project grant ID490028, a Royal Hobart Hospital Research Foundation grant and a University of Tasmania Institutional Research Grant.
Conflict of interest: Lung Foundation Australia/Boehringer Ingelheim chronic obstructive pulmonary disease (COPD) Research Fellowship for JW